menu
    • menu

    Company profile for NeuroTherapia

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NeuroTherpia, Inc., founded in 2015 by Cleveland Clinic Innovations based on research by Drs. Mohamed Naguib and Joseph Foss, on new therapies for diseases with an underlying component of neuroinflammation. Initial research has led to the development of our lead compound NTRX-07. NTRX-07 (previously known as MDA7) has been shown to decrease the activation of microglial cells in the brain. Decreasing activation of these cells l...
    NeuroTherpia, Inc., founded in 2015 by Cleveland Clinic Innovations based on research by Drs. Mohamed Naguib and Joseph Foss, on new therapies for diseases with an underlying component of neuroinflammation. Initial research has led to the development of our lead compound NTRX-07. NTRX-07 (previously known as MDA7) has been shown to decrease the activation of microglial cells in the brain. Decreasing activation of these cells leads to decreased inflammation and decreased injury to surrounding nerve cells. Decreasing this inflammation can treat and even prevent the development of neuropathic pain in settings of nerve injury or chemotherapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuroTherapiaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1500 Chagrin River Rd. Gates Mills, OH 44040
    Telephone
    Telephone
    216-870-7969
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neurotherapia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neurotherapia/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NeuroTherapia Gets EMA Approval for Ph 2 Alzheimer's Disease Trial
    NeuroTherapia Gets EMA Approval for Ph 2 Alzheimer's Disease Trial

    04 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurotherapia-announces-ema-approval-of-its-phase-2-trial-for-the-treatment-of-alzheimers-disease-302366418.html

    PR NEWSWIRE
    04 Feb 2025
    Share Share
    NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
    NeuroTherapia Raises $12.3M in the First Close of its Series B Financing

    06 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurotherapia-raises-12-3m-in-the-first-close-of-its-series-b-financing-302213518.html

    PR NEWSWIRE
    06 Aug 2024
    Share Share
    NeuroTherapia Receives Alzheimer's Grant For First-In-Class Drug
    NeuroTherapia Receives Alzheimer's Grant For First-In-Class Drug

    08 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurotherapia-receives-grant-from-alzheimers-association-for-development-of-first-in-class-drug-for-alzheimers-disease-302139707.html

    PR NEWSWIRE
    08 May 2024
    Share Share
    NeuroTherapia Presents Clinical Data from Phase 1b Clinical Trial of NTRX-07
    NeuroTherapia Presents Clinical Data from Phase 1b Clinical Trial of NTRX-07

    24 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/24/2765493/0/en/NeuroTherapia-Presents-Clinical-Data-from-Phase-1b-Clinical-Trial-of-NTRX-07-for-the-Treatment-of-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    24 Oct 2023
    Share Share
    NeuroTherapia Announces Completion of Phase 1a Clinical Trial
    NeuroTherapia Announces Completion of Phase 1a Clinical Trial

    02 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/neurotherapia-announces-completion-of-phase-1a-clinical-trial-301179041.html

    PRNEWSWIRE
    02 Dec 2020
    Share Share
    NeuroTherapia Announces Completion of Phase 1a Clinical Trial
    NeuroTherapia Announces Completion of Phase 1a Clinical Trial

    01 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/neurotherapia-announces-completion-of-phase-1a-clinical-trial-301179041.html

    PRNEWSWIRE
    01 Dec 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search